# Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis

> **NCT05408208** · NA · UNKNOWN · sponsor: **Sohag University** · enrollment: 30 (estimated)

## Conditions studied

- Localized Psoriasis

## Interventions

- **DRUG:** Intralesional Injection of Methotrexate
- **DRUG:** Triamcinolone Acetonid

## Key facts

- **NCT ID:** NCT05408208
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-21
- **Primary completion:** 2022-11-21
- **Final completion:** 2023-05-21
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05408208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05408208, "Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05408208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*